UBS Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.54M | Buy |
458,277
+230,384
| +101% | +$1.68M | ﹤0.01% | 4428 |
|
|
2025
Q4 | $1.4M | Buy |
227,893
+67,407
| +42% | +$728K | ﹤0.01% | 5289 |
|
|
2025
Q3 | $2.96M | Buy |
160,486
+105,042
| +189% | +$1.69M | ﹤0.01% | 4576 |
|
|
2025
Q2 | $721K | Sell |
55,444
-4,100
| -7% | -$48.5K | ﹤0.01% | 5710 |
|
|
2025
Q1 | $631K | Buy |
59,544
+6,473
| +12% | +$103K | ﹤0.01% | 5678 |
|
|
2024
Q4 | $901K | Buy |
53,071
+213
| +0.4% | +$4.01K | ﹤0.01% | 5384 |
|
|
2024
Q3 | $1.23M | Sell |
52,858
-9,301
| -15% | -$199K | ﹤0.01% | 4468 |
|
|
2024
Q2 | $1.51M | Sell |
62,159
-45,780
| -42% | -$1.39M | ﹤0.01% | 4038 |
|
|
2024
Q1 | $3.65M | Buy |
107,939
+35,231
| +48% | +$1.25M | ﹤0.01% | 3312 |
|
|
2023
Q4 | $2.29M | Buy |
72,708
+41,446
| +133% | +$985K | ﹤0.01% | 3660 |
|
|
2023
Q3 | $799K | Buy |
31,262
+14,260
| +84% | +$439K | ﹤0.01% | 4280 |
|
|
2023
Q2 | $488K | Sell |
17,002
-24,204
| -59% | -$659K | ﹤0.01% | 4846 |
|
|
2023
Q1 | $988K | Sell |
41,206
-43,916
| -52% | -$788K | ﹤0.01% | 4109 |
|
|
2022
Q4 | $1.44M | Buy |
85,122
+81,642
| +2,346% | +$1.42M | ﹤0.01% | 3716 |
|
|
2022
Q3 | $52K | Sell |
3,480
-33,366
| -91% | -$560K | ﹤0.01% | 6314 |
|
|
2022
Q2 | $580K | Sell |
36,846
-165,389
| -82% | -$3.25M | ﹤0.01% | 4148 |
|
|
2022
Q1 | $5.45M | Buy |
202,235
+103,205
| +104% | +$2.63M | ﹤0.01% | 2451 |
|
|
2021
Q4 | $3.67M | Buy |
99,030
+9,285
| +10% | +$378K | ﹤0.01% | 3174 |
|
|
2021
Q3 | $4.29M | Buy |
89,745
+55,774
| +164% | +$2.5M | ﹤0.01% | 2834 |
|
|
2021
Q2 | $1.15M | Sell |
33,971
-8,839
| -21% | -$299K | ﹤0.01% | 4061 |
|
|
2021
Q1 | $1.77M | Buy |
42,810
+14,682
| +52% | +$875K | ﹤0.01% | 3683 |
|
|
2020
Q4 | $1.22M | Buy |
28,128
+14,200
| +102% | +$962K | ﹤0.01% | 3853 |
|
|
2020
Q3 | $597K | Sell |
13,928
-1,960
| -12% | -$97.3K | ﹤0.01% | 4039 |
|
|
2020
Q2 | $743K | Buy |
15,888
+15,639
| +6,281% | +$539K | ﹤0.01% | 3783 |
|
|
2020
Q1 | $3K | Sell |
249
-308
| -55% | -$3.94K | ﹤0.01% | 7464 |
|
|
2019
Q4 | $6K | Buy |
+557
| New | +$5.83K | ﹤0.01% | 7497 |
|
|
2019
Q3 | – | Sell |
-2,919
| Closed | -$28K | – | 7974 |
|
|
2019
Q2 | $28K | Buy |
+2,919
| New | +$21.4K | ﹤0.01% | 6380 |
|
|
2019
Q1 | – | Sell |
-1,318
| Closed | -$6K | – | 7710 |
|
|
2018
Q4 | $6K | Sell |
1,318
-1,218
| -48% | -$7.49K | ﹤0.01% | 7465 |
|
|
2018
Q3 | $22K | Buy |
+2,536
| New | +$21.1K | ﹤0.01% | 6746 |
|
|
2018
Q2 | – | Sell |
-1,879
| Closed | -$10K | – | 7962 |
|
|
2018
Q1 | $10K | Buy |
1,879
+739
| +65% | +$5.1K | ﹤0.01% | 6846 |
|
|
2017
Q4 | $9K | Buy |
1,140
+166
| +17% | +$1.49K | ﹤0.01% | 7074 |
|
|
2017
Q3 | $7K | Buy |
+974
| New | +$7.34K | ﹤0.01% | 7052 |
|
|
2017
Q2 | – | Sell |
-119
| Closed | -$1K | – | 7640 |
|
|
2017
Q1 | $1K | Buy |
+119
| New | +$1.1K | ﹤0.01% | 7397 |
|
|
2016
Q4 | – | Sell |
-994
| Closed | -$17K | – | 7754 |
|
|
2016
Q3 | $17K | Buy |
994
+30
| +3% | +$969 | ﹤0.01% | 6423 |
|
|
2016
Q2 | $30K | Buy |
964
+669
| +227% | +$21.1K | ﹤0.01% | 5929 |
|
|
2016
Q1 | $8K | Sell |
295
-127
| -30% | -$4.3K | ﹤0.01% | 6772 |
|
|
2015
Q4 | $19K | Buy |
422
+365
| +640% | +$16.4K | ﹤0.01% | 6794 |
|
|
2015
Q3 | $2K | Sell |
57
-1,073
| -95% | -$56.4K | ﹤0.01% | 8055 |
|
|
2015
Q2 | $52K | Buy |
1,130
+581
| +106% | +$26.6K | ﹤0.01% | 5979 |
|
|
2015
Q1 | $21K | Buy |
549
+492
| +863% | +$21.6K | ﹤0.01% | 6932 |
|
|
2014
Q4 | $1K | Buy |
+57
| New | +$1.81K | ﹤0.01% | 9520 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
